1998
DOI: 10.1001/archopht.116.11.1514
|View full text |Cite
|
Sign up to set email alerts
|

Cytokine Therapy in Eye Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2000
2000
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 41 publications
0
2
0
1
Order By: Relevance
“…Judging from results concerning other inflammatory processes [4,8], it would be reasonable to theorize a role of inflammatory cytokines in that condition. Cytokines are polypeptides that act as intercellular messengers [19,24], playing an important role in mediating the processes of inflammation and repair. Macrophages, lymphocytes, natural killers, and other immune cells, even endothelial cells, participate in the secretion of numerous signal molecules [9,26], which, in turn, recruit more inflammatory cells and regulate host immune responses to an injury or antigen invasion [20].…”
Section: Introductionmentioning
confidence: 99%
“…Judging from results concerning other inflammatory processes [4,8], it would be reasonable to theorize a role of inflammatory cytokines in that condition. Cytokines are polypeptides that act as intercellular messengers [19,24], playing an important role in mediating the processes of inflammation and repair. Macrophages, lymphocytes, natural killers, and other immune cells, even endothelial cells, participate in the secretion of numerous signal molecules [9,26], which, in turn, recruit more inflammatory cells and regulate host immune responses to an injury or antigen invasion [20].…”
Section: Introductionmentioning
confidence: 99%
“…Being female and Latina, the patient fits the characteristic VKH profile. Both interferon and ribavirin can induce a TH1‐type response, the milieu associated with both VKH and experimental autoimmune uveoretinitis [10,19,20,48]. IFN‐alpha may also alter the expression of MHC class II antigens, another characteristic associated with the development of VKH disease [10,35].…”
Section: Evidence For Causalitymentioning
confidence: 99%
“…Инфликсимаб с высокой специфичностью блокирует как циркулирующий, так и фиксированный на клеточных мембранах ФНОα. Впервые инфликсимаб применили для лечения увеита при ББ, о чем было сообщено в публикациях японских и греческих авторов [7,8]. Позднее появились работы об успешном применении инфликсимаба в лечении АС с проявлениями увеита [9,10].…”
unclassified